BSX

HOLD

Boston Scientific Corporation

Healthcare · Rank #73 · Analyzed Apr 20, 2026

$64.23

Current Price

$72.11

Intrinsic Value

+118.0%

Upside/Downside

8.5/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score3.5/5.0

Framework RatingHOLD

Price vs Intrinsic ValueUndervalued by 118.0%

Fair Value Range

Low$13.17

Base (IV)$72.11

High$140.03

Entry Points

Conservative$13.17

Moderate$42.64

Aggressive$72.11

Quality & Moat Breakdown

Return on Equity12.4% → 0.5/1.0

Debt LevelD/E 49 → 0.5/1.0

Revenue QualityGrowth 18.7%, margin Δ+3.7% +recovery → 1.0/1.0

Moat Strength3.0/5 → 0.5/1.0

Profit Margins14.4% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.